These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11393348)

  • 1. Chronic obstructive pulmonary disease.
    Anzueto A
    J Int Med Res; 2001; 29(2):49-50. PubMed ID: 11393348
    [No Abstract]   [Full Text] [Related]  

  • 2. [Moxifloxacin: results of clinical use].
    Iakovlev VP; Polushkina NR
    Antibiot Khimioter; 2002; 47(10):32-6. PubMed ID: 12674792
    [No Abstract]   [Full Text] [Related]  

  • 3. An updated safety profile of moxifloxacin.
    Iannini PB; Mandell LA
    J Chemother; 2002 Feb; 14 Suppl 2():29-34. PubMed ID: 12003138
    [No Abstract]   [Full Text] [Related]  

  • 4. Reassuring safety profile of moxifloxacin.
    Iannini PB; Kubin R; Reiter C; Tillotson G
    Clin Infect Dis; 2001 Apr; 32(7):1112-4. PubMed ID: 11264046
    [No Abstract]   [Full Text] [Related]  

  • 5. [The safety of new quinolone treatment--levoflaxacin (tavanic) and moxiflocacin (megaxin)-- in the community].
    Bolkovshtein M; Lederman N; Berkovitch M
    Harefuah; 2001 Nov; 140(11):1054-7. PubMed ID: 11759381
    [No Abstract]   [Full Text] [Related]  

  • 6. Anaphylactoid reaction caused by moxifloxacin.
    Alemán AM; Quirce S; Cuesta J; Novalbos A; Sastre J
    J Investig Allergol Clin Immunol; 2002; 12(1):67-8. PubMed ID: 12109537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Perspectives of use of moxifloxacin for treatment of urogenital infections].
    Sidorenko SV
    Antibiot Khimioter; 2002; 47(1):36-42. PubMed ID: 12077939
    [No Abstract]   [Full Text] [Related]  

  • 8. [Moxifloxacin--a novel antimicrobial preparation for treatment of respiratory infections].
    Iakovlev SV; Polushkina NR; Iakovlev VP
    Ter Arkh; 2001; 73(11):15-22. PubMed ID: 11806197
    [No Abstract]   [Full Text] [Related]  

  • 9. Moxifloxacin-induced acute liver injury.
    Soto S; López-Rosés L; Avila S; Lancho A; González A; Santos E; Urraca B
    Am J Gastroenterol; 2002 Jul; 97(7):1853-4. PubMed ID: 12135060
    [No Abstract]   [Full Text] [Related]  

  • 10. Gatifloxacin and moxifloxacin: two new fluoroquinolones.
    Med Lett Drugs Ther; 2000 Feb; 42(1072):15-7. PubMed ID: 10705891
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluoroquinolones in chronic obstructive pulmonary disease.
    Colville A; Knowles M; Large D; George J; Mustchin P
    BMJ; 1994 May; 308(6941):1437. PubMed ID: 8019265
    [No Abstract]   [Full Text] [Related]  

  • 12. Moxifloxacin-induced Clostridium difficile diarrhea.
    Ortiz-de-Saracho J; Pantoja L; Romero MJ; López R
    Ann Pharmacother; 2003 Mar; 37(3):452-3. PubMed ID: 12639182
    [No Abstract]   [Full Text] [Related]  

  • 13. [Moxifloxacin].
    Caballero E; Cárdenas E; Gurucharri N; Rodrigo A; Honorato J
    Rev Med Univ Navarra; 2000; 44(4):53-60. PubMed ID: 11341057
    [No Abstract]   [Full Text] [Related]  

  • 14. [Playing it safe in bronchopulmonary infections].
    MMW Fortschr Med; 2003 May; 145(18):57. PubMed ID: 12838909
    [No Abstract]   [Full Text] [Related]  

  • 15. [New antibiotics in primary care].
    Horcajada JP; Martínez JA
    Rev Esp Quimioter; 2003 Mar; 16(1):118-22. PubMed ID: 12760359
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effectiveness of a new fluoroquinolone antibiotic avelox in the treatment of suppurative sinusitis].
    Egorov VI; Kozarenko AV
    Vestn Otorinolaringol; 2002; (5):35-6. PubMed ID: 12524963
    [No Abstract]   [Full Text] [Related]  

  • 17. [Respiratory tract infections. Increasingly more established antibiotics fail].
    MMW Fortschr Med; 2002 Oct; 144(42):65. PubMed ID: 12534005
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical perspectives on new antimicrobials: focus on fluoroquinolones.
    Talan DA
    Clin Infect Dis; 2001 Mar; 32 Suppl 1():S64-71. PubMed ID: 11249831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moxifloxacin (Avelox) for the treatment of bacterial skin infections.
    Parish LC; Witkowski JA; Routh HB
    Skin Therapy Lett; 2001 Oct; 6(11):1-2. PubMed ID: 11719825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fatal acute hepatitis and cholestasis associated with liver disease].
    Puerto Alonso JL; Díaz Souza P; Chamorro Mohedano J; Rojas Martín E
    Med Clin (Barc); 2010 Mar; 134(8):375-6. PubMed ID: 19447449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.